Opiant Pharmaceuticals to Report Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 14, 2022
October 27 2022 - 4:05PM
Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ:
OPNT), a specialty pharmaceutical company developing medicines to
treat addictions and drug overdose, today announced it will
report its financial results for the third quarter ended September
30, 2022, after the financial markets close on Monday,
November 14, 2022.
The Company’s management team is scheduled to host a conference
call and webcast at 4:30 p.m. ET on Monday, November
14, 2022. To access the call, please dial 1-877-407-0792 in
the U.S. or 1-201-689-8263 outside the U.S. and
provide the conference ID number: 13732765. To access the live
webcast, please visit
https://viavid.webcasts.com/starthere.jsp?ei=1569474&tp_key=bb26315c9c.
Following the live webcast, an archived version of the call will be
available on the website.
Monday November 14 @ 4:30 pm
ET |
Domestic: |
1-877-407-0792 |
International: |
1-201-689-8263 |
Conference ID: |
13732765 |
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1569474&tp_key=bb26315c9c |
About Opiant Pharmaceuticals,
Inc.Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a
leading franchise of new medicines to combat addictions
and drug overdose. For more information
visit: www.opiant.com.
For Media and Investor Inquiries:Ben Atkins,
Opiant(310) 598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Apr 2023 to Apr 2024